Insider Trading activities of Sgx Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sgx Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sgx Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Sgx Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is SGXP. The reporting company's CIK number is 1125603.
The total value of stock buying since 2005 is $6,141,713.
The total value of stock sales since 2005 is $198,954.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Sgx Pharmaceuticals, Inc. (SGXP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-08 0 $0 1,562 $4,638 3,125 $0
2008-07 1,298,100 $3,939,091 1,562 $3,634 3,125 $0
2008-06 1,105,257 $1,602,622 1,562 $2,342 3,125 $0
2008-05 0 $0 1,562 $2,248 3,125 $0
2008-04 0 $0 1,562 $1,977 3,125 $0
2008-03 0 $0 3,124 $12,556 6,251 $0
2008-02 0 $0 1,562 $6,599 3,125 $0
2008-01 0 $0 1,562 $7,489 3,125 $0
2007-12 0 $0 1,562 $7,496 3,125 $0
2007-11 0 $0 1,562 $9,059 3,125 $0
2007-10 0 $0 1,562 $9,856 3,125 $0
2007-09 0 $0 1,562 $9,631 3,125 $0
2007-08 0 $0 1,562 $10,195 3,125 $0
2007-07 0 $0 1,562 $8,887 3,125 $0
2007-06 0 $0 1,562 $8,158 3,125 $0
2007-05 0 $0 1,562 $7,985 3,125 $0
2007-04 0 $0 1,562 $7,522 3,125 $0
2007-03 0 $0 1,562 $8,090 3,125 $0
2007-02 0 $0 1,562 $7,231 3,125 $0
2007-01 0 $0 10,156 $35,330 20,312 $0
2006-12 0 $0 9,375 $28,031 18,750 $0
2006-02 100,000 $600,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Sgx Pharmaceuticals, Inc. insiders (SGXP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-08-15 Reich Siegfried (VP, Drug Discovery) Sale 781 2.98 2,327
2008-08-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2008-08-05 Myers W Todd (CFO) Sale 781 2.96 2,311
2008-08-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2008-07-15 Reich Siegfried (VP, Drug Discovery) Sale 781 3.06 2,385
2008-07-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2008-07-11 Bvf Inc/il (Other) Buy 12,500 3.07 38,362
2008-07-10 Bvf Inc/il (Other) Buy 403,200 3.03 1,221,292
2008-07-09 Bvf Inc/il (Other) Buy 800,300 3.04 2,433,712
2008-07-08 Bvf Inc/il (Other) Buy 82,100 2.99 245,725
2008-07-07 Myers W Todd (CFO) Sale 781 1.60 1,249
2008-07-07 Myers W Todd (CFO) Option Ex 1,562 .00 0
2008-06-18 Bvf Inc/il (Other) Buy 1,105,257 1.45 1,602,622
2008-06-16 Reich Siegfried (VP, Drug Discovery) Sale 781 1.65 1,288
2008-06-16 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2008-06-05 Myers W Todd (CFO) Sale 781 1.35 1,054
2008-06-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2008-05-15 Reich Siegfried (VP, Drug Discovery) Sale 781 1.45 1,132
2008-05-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2008-05-05 Myers W Todd (CFO) Sale 781 1.43 1,116
2008-05-05 Myers W Todd (CFO) Option Ex 1,562 .00 0
2008-04-15 Reich Siegfried (VP, Drug Discovery) Sale 781 1.19 929
2008-04-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2008-04-07 Myers W Todd (CFO) Sale 781 1.34 1,048
2008-04-07 Myers W Todd (CFO) Option Ex 1,563 .00 0
2008-03-17 Reich Siegfried (VP, Drug Discovery) Sale 1,562 4.01 6,262
2008-03-17 Reich Siegfried (VP, Drug Discovery) Option Ex 3,126 .00 0
2008-03-05 Myers W Todd (CFO) Sale 781 4.05 3,163
2008-03-05 Myers W Todd (CFO) Option Ex 1,562 .00 0
2008-02-15 Reich Siegfried (VP, Drug Discovery) Sale 781 4.05 3,163
2008-02-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2008-02-05 Myers W Todd (CFO) Sale 781 4.40 3,436
2008-02-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2008-01-15 Reich Siegfried (VP, Drug Discovery) Sale 781 4.44 3,467
2008-01-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2008-01-07 Myers W Todd (CFO) Sale 781 5.15 4,022
2008-01-07 Myers W Todd (CFO) Option Ex 1,562 .00 0
2007-12-17 Reich Siegfried (VP, Drug Discovery) Sale 781 4.75 3,709
2007-12-17 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2007-12-05 Myers W Todd (CFO) Sale 781 4.85 3,787
2007-12-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2007-11-15 Reich Siegfried (VP, Drug Discovery) Sale 781 5.10 3,983
2007-11-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2007-11-05 Myers W Todd (CFO) Sale 781 6.50 5,076
2007-11-05 Myers W Todd (CFO) Option Ex 1,562 .00 0
2007-10-15 Reich Siegfried (VP, Drug Discovery) Sale 781 6.42 5,014
2007-10-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2007-10-05 Myers W Todd (CFO) Sale 781 6.20 4,842
2007-10-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2007-09-17 Reich Siegfried (VP, Drug Discovery) Sale 781 6.20 4,842
2007-09-17 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2007-09-05 Myers W Todd (CFO) Sale 781 6.13 4,789
2007-09-05 Myers W Todd (CFO) Option Ex 1,562 .00 0
2007-08-15 Reich Siegfried (VP, Drug Discovery) Sale 781 6.42 5,017
2007-08-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2007-08-06 Myers W Todd (CFO) Sale 781 6.63 5,178
2007-08-06 Myers W Todd (CFO) Option Ex 1,563 .00 0
2007-07-16 Reich Siegfried (VP, Drug Discovery) Sale 781 6.05 4,725
2007-07-16 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2007-07-05 Myers W Todd (CFO) Sale 781 5.33 4,162
2007-07-05 Myers W Todd (CFO) Option Ex 1,562 .00 0
2007-06-15 Reich Siegfried (VP, Drug Discovery) Sale 781 5.15 4,019
2007-06-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2007-06-05 Myers W Todd (CFO) Sale 781 5.30 4,139
2007-06-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2007-05-15 Reich Siegfried (VP, Drug Discovery) Sale 781 5.18 4,049
2007-05-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2007-05-07 Myers W Todd (CFO) Sale 781 5.04 3,936
2007-05-05 Myers W Todd (CFO) Option Ex 1,562 .00 0
2007-04-16 Reich Siegfried (VP, Drug Discovery) Sale 781 5.02 3,922
2007-04-16 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2007-04-05 Myers W Todd (CFO) Sale 781 4.61 3,600
2007-04-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2007-03-15 Reich Siegfried (VP, Drug Discovery) Sale 781 5.53 4,318
2007-03-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,563 .00 0
2007-03-05 Myers W Todd (CFO) Sale 781 4.83 3,772
2007-03-05 Myers W Todd (CFO) Option Ex 1,562 .00 0
2007-02-15 Reich Siegfried (VP, Drug Discovery) Sale 781 5.36 4,186
2007-02-15 Reich Siegfried (VP, Drug Discovery) Option Ex 1,562 .00 0
2007-02-05 Myers W Todd (CFO) Sale 781 3.90 3,045
2007-02-05 Myers W Todd (CFO) Option Ex 1,563 .00 0
2007-01-16 Reich Siegfried (Vice President, Drug Discovery) Sale 9,375 3.50 32,812
2007-01-16 Reich Siegfried (Vice President, Drug Discovery) Option Ex 18,750 .00 0
2007-01-05 Myers W Todd (Chief Financial Officer) Sale 781 3.22 2,518
2007-01-05 Myers W Todd (Chief Financial Officer) Option Ex 1,562 .00 0
2006-12-05 Myers W Todd (Chief Financial Officer) Sale 9,375 2.99 28,031
2006-12-05 Myers W Todd (Chief Financial Officer) Option Ex 18,750 .00 0
2006-02-06 Lathi Vijay K (Director) Buy 100,000 6.00 600,000

Insider trading activities including stock purchases, stock sales, and option exercises of SGXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sgx Pharmaceuticals, Inc. (symbol SGXP, CIK number 1125603) see the Securities and Exchange Commission (SEC) website.